Cargando…
Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
The outbreak of viral pneumonia caused by the novel coronavirus SARS-CoV-2 that began in December 2019 caused high mortality. It has been suggested that the main protease (Mpro) of SARS-CoV-2 may be an important target to discover pharmaceutical compounds for the therapy of this life-threatening dis...
Autores principales: | Cheng, Bijun, Li, Tianjiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273901/ https://www.ncbi.nlm.nih.gov/pubmed/32459144 http://dx.doi.org/10.2144/btn-2020-0038 |
Ejemplares similares
-
Study on the multitarget mechanism of alliin activating autophagy based on network pharmacology and molecular docking
por: Cheng, Bijun, et al.
Publicado: (2022) -
Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
por: Cardoso, Wesley B., et al.
Publicado: (2021) -
Discovery and Mechanism
of SARS-CoV-2 Main
Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021) -
Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
por: Grover, Vishakha, et al.
Publicado: (2022) -
Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)